MedTech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MedTech and buy or sell other stocks, ETFs, and their options commission-free!About MTAC
TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020, and is headquartered in Westminster, CO.
CEOMary T. Szela, MBA
CEOMary T. Szela, MBA
Employees110
Employees110
HeadquartersWestminster, Colorado
HeadquartersWestminster, Colorado
Founded
Founded
Employees110
Employees110
MTAC Key Statistics
Market cap342.25M
Market cap342.25M
Price-Earnings ratio-3.40
Price-Earnings ratio-3.40
Dividend yield—
Dividend yield—
Average volume281.90K
Average volume281.90K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$7.95
52 Week high$7.95
52 Week low$3.42
52 Week low$3.42
Stock Snapshot
The current MedTech(MTAC) stock price is $6.86, with a market capitalization of 342.25M. The stock trades at a price-to-earnings (P/E) ratio of -3.40.
MedTech(MTAC) stock opened on 2025-12-29 at —. The price climbed to — and dipped to —.
MedTech(MTAC) shares are trading with a volume of 0, against a daily average of 281.9K.
In the last year, MedTech(MTAC) shares hit a 52-week high of $7.95 and a 52-week low of $3.42.
In the last year, MedTech(MTAC) shares hit a 52-week high of $7.95 and a 52-week low of $3.42.
People also own
Based on the portfolios of people who own MTAC. This list is generated using Robinhood data, and it’s not a recommendation.